Both in Biotechnology
Elutia vs Pelthos Therapeutics
Over the past year ELUT returned −21.8% and PTHS returned −74.9%; their daily moves had a correlation of 0.05.
ELUT −21.8% PTHS −74.9%Growth of $1, one year, split-adjusted
| Metric | ELUT | PTHS |
|---|---|---|
| Price | $0.7509 | $9.30 |
| Market cap | $33.3M | $36.6M |
| Today | −1.15% | −8.37% |
| 1 month | −8.4% | −55.7% |
| 6 months | −24.8% | −62.8% |
| Year to date | +8.4% | −70.0% |
| 1 year | −18.4% | — |
| Revenue growth (YoY) | −11.6% | — |
| Gross margin | 59.6% | 76.9% |
| Net margin | −315.0% | −150.1% |
| P/E (TTM) | 0.6× | — |
| Price / sales | 2.7× | 0.8× |
| Net cash | $19.9M | -$45.7M |
| Dividend yield | — | — |
| Volatility (60d) | 62.2% | 141.3% |
| Short % of float | 0.0% | 8.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).